Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Gilead Sciences (GILD) Short Interest Ratio & Short Volume

Gilead Sciences logo
$112.56 -1.36 (-1.19%)
Closing price 04:00 PM Eastern
Extended Trading
$112.56 0.00 (0.00%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Gilead Sciences Short Interest Data

Gilead Sciences (GILD) has a short interest of 19.99 million shares, representing 1.61% of the float (the number of shares available for trading by the public). This marks a -11.31% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 8.18 million shares to cover all short positions.

Current Short Interest
19,990,000 shares
Previous Short Interest
22,540,000 shares
Change Vs. Previous Month
-11.31%
Dollar Volume Sold Short
$2.24 billion
Short Interest Ratio
2.6 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
1,240,807,000 shares
Float Size
1,240,000,000 shares
Short Percent of Float
1.61%
Today's Trading Volume
4,127,007 shares
Average Trading Volume
8,181,580 shares
Today's Volume Vs. Average
50%
Short Selling Gilead Sciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GILD Short Interest Over Time

GILD Days to Cover Over Time

GILD Percentage of Float Shorted Over Time

Gilead Sciences Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202519,990,000 shares $2.24 billion -11.3%1.6%2.6 $112.29
7/15/202522,540,000 shares $2.46 billion +7.4%1.8%2.8 $109.06
6/30/202520,990,000 shares $2.33 billion -8.7%1.7%2.4 $110.87
6/15/202522,990,000 shares $2.53 billion +9.8%1.9%2.5 $109.98
5/31/202520,940,000 shares $2.31 billion -15.2%1.7%2.2 $110.35
5/15/202524,680,000 shares $2.48 billion +4.7%2.0%2.5 $100.34
4/30/202523,570,000 shares $2.51 billion +17.4%1.9%2.4 $106.54
4/15/202520,080,000 shares $2.12 billion -6.1%1.6%2.1 $105.68
3/31/202521,390,000 shares $2.40 billion -4.3%1.7%2.3 $112.05
3/15/202522,340,000 shares $2.49 billion -1.1%1.8%2.7 $111.44
2/28/202522,580,000 shares $2.58 billion +6.7%1.8%2.9 $114.31
2/15/202521,160,000 shares $2.20 billion -7.7%1.7%3 $104.08
1/31/202522,930,000 shares $2.23 billion -8.9%1.9%3.2 $97.20
1/15/202525,170,000 shares $2.33 billion -1.9%2.0%3.6 $92.38
12/31/202425,660,000 shares $2.37 billion +16.7%2.1%4 $92.37
12/15/202421,980,000 shares $2.02 billion -6.1%1.8%3.3 $91.86
11/30/202423,410,000 shares $2.17 billion +29.6%1.9%3.4 $92.58
11/15/202418,060,000 shares $1.60 billion +1.8%1.5%2.7 $88.40
10/31/202417,740,000 shares $1.58 billion +7.7%1.4%2.8 $88.82
10/15/202416,480,000 shares $1.41 billion -7.1%1.3%2.7 $85.82
9/30/202417,740,000 shares $1.49 billion -11.1%1.4%2.7 $83.84
9/15/202419,950,000 shares $1.65 billion +0.8%1.6%3 $82.81
8/31/202419,800,000 shares $1.56 billion +18.1%1.6%2.8 $79.00
8/15/202416,770,000 shares $1.25 billion -6.0%1.4%2.3 $74.34
7/31/202417,840,000 shares $1.36 billion -16.1%1.4%2.4 $76.06
7/15/202421,250,000 shares $1.50 billion -7.6%1.7%2.8 $70.81
6/30/202423,000,000 shares $1.58 billion +22.3%1.9%3.1 $68.61
6/15/202418,810,000 shares $1.22 billion -26.0%1.5%2.5 $65.06
5/31/202425,430,000 shares $1.63 billion +17.2%2.1%3.6 $64.27
5/15/202421,700,000 shares $1.45 billion +2.6%1.8%3.2 $67.01
4/30/202421,160,000 shares $1.38 billion -0.1%N/A2.9 $65.20
4/15/202421,180,000 shares $1.43 billion -6.2%N/A2.9 $67.75
3/31/202422,570,000 shares $1.65 billion +17.3%N/A3 $73.25
3/15/202419,250,000 shares $1.42 billion -2.1%1.6%2.7 $73.69
2/29/202419,670,000 shares $1.42 billion -1.1%1.6%2.7 $72.10
2/15/202419,880,000 shares $1.46 billion +27.0%1.6%2.8 $73.37
1/31/202415,660,000 shares $1.23 billion -8.6%1.3%2.2 $78.26
1/15/202417,140,000 shares $1.48 billion +0.6%1.4%2.6 $86.38
12/31/202317,040,000 shares $1.38 billion -7.9%N/A2.7 $81.01
12/15/202318,500,000 shares $1.49 billion +6.2%N/A3 $80.33
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
11/30/202317,420,000 shares $1.33 billion -3.9%N/A3 $76.60
11/15/202318,130,000 shares $1.36 billion -7.0%N/A3.3 $75.04
10/31/202319,500,000 shares $1.53 billion -4.2%1.6%3.6 $78.54
10/15/202320,350,000 shares $1.58 billion +0.5%1.6%3.9 $77.65
9/30/202320,240,000 shares $1.52 billion +10.4%1.6%3.8 $74.94
9/15/202318,330,000 shares $1.39 billion +0.4%1.5%3.3 $75.67
8/31/202318,250,000 shares $1.40 billion -7.0%1.5%3.2 $76.48
8/15/202319,630,000 shares $1.56 billion +4.2%1.6%3.4 $79.64
7/31/202318,840,000 shares $1.43 billion +7.2%N/A3.3 $76.14
7/15/202317,570,000 shares $1.36 billion +1.3%N/A3 $77.19
6/30/202317,340,000 shares $1.34 billion +6.3%N/A3.2 $77.07
6/15/202316,320,000 shares $1.29 billion +6.8%N/A3 $79.00
5/31/202315,280,000 shares $1.18 billion -15.0%N/A2.7 $76.94
5/15/202317,980,000 shares $1.41 billion -6.7%N/A3.4 $78.38
4/30/202319,280,000 shares $1.59 billion +26.4%N/A3.4 $82.21
4/15/202315,250,000 shares $1.27 billion -1.5%N/A2.6 $83.00
3/31/202315,480,000 shares $1.28 billion +1.8%N/A2.6 $82.97
3/15/202315,200,000 shares $1.21 billion -2.9%N/A2.5 $79.65
2/28/202315,660,000 shares $1.26 billion -0.6%N/A2.3 $80.53
2/15/202315,760,000 shares $1.34 billion +3.9%N/A2.3 $85.05
1/31/202315,170,000 shares $1.27 billion +1.6%N/A2.1 $83.94
1/15/202314,930,000 shares $1.29 billion -8.0%N/A1.9 $86.27
12/30/202216,220,000 shares $1.39 billion +9.9%N/A2.1 $85.85
12/15/202214,760,000 shares $1.28 billion -16.0%N/A1.8 $86.58
11/30/202217,560,000 shares $1.54 billion -15.3%N/A2.1 $87.83
11/15/202220,730,000 shares $1.72 billion +8.7%N/A2.5 $83.00
10/31/202219,070,000 shares $1.50 billion +15.8%N/A2.4 $78.46
10/15/202216,470,000 shares $1.09 billion +0.1%N/A2.3 $66.17
9/30/202216,450,000 shares $1.01 billion -1.4%N/A2.4 $61.69
9/15/202216,690,000 shares $1.08 billion -0.5%N/A2.5 $65.00
8/31/202216,770,000 shares $1.06 billion -1.6%N/A2.5 $63.47
8/15/202217,040,000 shares $1.13 billion +20.3%N/A2.5 $66.21
7/31/202214,160,000 shares $846.06 million -14.5%N/A2 $59.75
7/15/202216,560,000 shares $1.04 billion +13.0%N/A2.2 $62.60
6/30/202214,650,000 shares $905.52 million -6.4%N/A1.9 $61.81
6/15/202215,650,000 shares $913.80 million +6.6%N/A1.9 $58.39
5/31/202214,680,000 shares $952.00 million -12.9%N/A1.7 $64.85
5/15/202216,850,000 shares $1.05 billion +0.9%N/A1.7 $62.37
4/30/202216,700,000 shares $990.98 million +8.7%N/A1.6 $59.34
4/15/202215,370,000 shares $950.17 million +6.3%N/A1.4 $61.82
3/31/202214,460,000 shares $859.65 million -2.6%N/A1.3 $59.45
3/15/202214,840,000 shares $865.47 million -20.3%N/A1.4 $58.32
2/28/202218,630,000 shares $1.13 billion -16.2%N/A1.9 $60.40
2/15/202222,240,000 shares $1.36 billion -7.9%N/A2.3 $61.33
1/31/202224,150,000 shares $1.66 billion +10.4%N/A2.9 $68.68
1/15/202221,880,000 shares $1.57 billion +2.7%N/A0 $71.77
12/31/202121,300,000 shares $1.55 billion -4.1%N/A3 $72.61
12/15/202122,200,000 shares $1.58 billion +1.4%N/A3.2 $71.21
11/30/202121,890,000 shares $1.51 billion -5.3%N/A3.2 $68.93
11/15/202123,120,000 shares $1.55 billion +5.5%N/A3.5 $67.20
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/29/202121,920,000 shares $1.42 billion -8.7%N/A3.4 $64.88
10/15/202124,010,000 shares $1.62 billion -1.1%N/A3.8 $67.63
9/30/202124,280,000 shares $1.70 billion +16.2%N/A3.9 $69.85
9/15/202120,900,000 shares $1.50 billion -6.9%N/A3.4 $71.76
8/31/202122,450,000 shares $1.63 billion -12.7%N/A3.7 $72.78
8/13/202125,700,000 shares $1.83 billion -0.1%N/A4.1 $71.16
7/30/202125,730,000 shares $1.76 billion -5.5%N/A4 $68.29
7/15/202127,220,000 shares $1.86 billion +12.3%N/A4.1 $68.30
6/30/202124,230,000 shares $1.67 billion +0.9%N/A3.5 $68.86
6/15/202124,020,000 shares $1.64 billion +1.4%N/A3.4 $68.09
5/28/202123,690,000 shares $1.57 billion -7.9%N/A3.2 $66.11
5/14/202125,720,000 shares $1.77 billion -10.2%2.1%3.3 $68.91
4/30/202128,640,000 shares $1.83 billion +10.1%2.3%3.7 $63.84
4/15/202126,010,000 shares $1.70 billion +11.0%2.1%3.4 $65.30
3/31/202123,440,000 shares $1.54 billion +4.1%1.9%2.8 $65.50
3/15/202122,520,000 shares $1.39 billion -5.5%1.8%2.4 $61.56
2/26/202123,830,000 shares $1.50 billion +3.1%1.9%2.6 $62.79
2/12/202123,110,000 shares $1.55 billion +7.1%1.9%2.6 $66.92
1/29/202121,580,000 shares $1.40 billion -3.5%1.7%2.3 $64.68
1/15/202122,370,000 shares $1.40 billion +3.7%1.8%2.3 $62.40
12/31/202021,570,000 shares $1.22 billion +22.1%1.7%2.2 $56.65
12/15/202017,670,000 shares $1.06 billion -14.8%1.4%1.9 $59.84
11/30/202020,730,000 shares $1.24 billion -4.5%1.7%2.2 $60.03
11/15/202021,710,000 shares $1.32 billion -4.4%1.7%2.3 $60.59
10/30/202022,700,000 shares $1.33 billion +10.7%1.8%2.4 $58.53
10/15/202020,500,000 shares $1.31 billion +5.9%1.6%2.1 $64.05
9/30/202019,360,000 shares $1.22 billion +7.9%1.6%2.2 $63.19
9/15/202017,950,000 shares $1.19 billion +11.0%1.4%2.1 $66.20
8/31/202016,170,000 shares $1.08 billion -14.1%1.3%1.9 $66.75

GILD Short Interest - Frequently Asked Questions

What is Gilead Sciences' current short interest?

Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 19,990,000 shares of GILD short. 1.61% of Gilead Sciences' shares are currently sold short. Learn More on Gilead Sciences' current short interest.

What is a good short interest ratio for Gilead Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 3.0. Learn More on Gilead Sciences's short interest ratio.

Which institutional investors are shorting Gilead Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Hudson Bay Capital Management LP, Wolverine Trading LLC, Nomura Holdings Inc., Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Caption Management LLC, Squarepoint Ops LLC, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Qube Research & Technologies Ltd, Lombard Odier Asset Management USA Corp, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Delta Accumulation LLC, Mackenzie Financial Corp, Hsbc Holdings PLC, Capital Fund Management S.A., DLD Asset Management LP, Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Mirae Asset Securities USA Inc., Simplex Trading LLC, Bank of New York Mellon Corp, Bank of Montreal Can, Allianz Asset Management GmbH, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Gilead Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.61% of Gilead Sciences' floating shares are currently sold short.

Is Gilead Sciences' short interest increasing or decreasing?

Gilead Sciences saw a decline in short interest in July. As of July 31st, there was short interest totaling 19,990,000 shares, a decline of 11.3% from the previous total of 22,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Gilead Sciences' float size?

Gilead Sciences currently has issued a total of 1,240,810,000 shares. Some of Gilead Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gilead Sciences currently has a public float of 1,240,000,000 shares.

How does Gilead Sciences' short interest compare to its competitors?

1.61% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Gilead Sciences: Ligand Pharmaceuticals Incorporated (5.10%), Moderna, Inc. (18.29%), Regeneron Pharmaceuticals, Inc. (2.24%), Vir Biotechnology, Inc. (12.44%), Vertex Pharmaceuticals Incorporated (1.71%), AbbVie Inc. (0.86%), Merck & Co., Inc. (1.04%), Pfizer Inc. (1.90%), Amgen Inc. (2.33%), Alnylam Pharmaceuticals, Inc. (2.51%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Gilead Sciences stock?

Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. GILD shares are trading down $0.83 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gilead Sciences?

A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further.

How often is Gilead Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:GILD) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsoredtc pixel
Trump's "Big Beautiful Bill" hides ugly truth
Washington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...
Defi Master | Sponsoredtc pixel
Trump’s national nightmare is here
AI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...
Porter & Company | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...
Weiss Ratings | Sponsoredtc pixel
Is This Stock the 'Next Nvidia'?
'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...
Altimetry | Sponsoredtc pixel